Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review

Synapse

Volumn 65, Issue 9, 2011, Pages 892-909

  Cumming, Paul ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Autoradiography; D1; D2; DA; PET; Receptors; Saturation binding

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BUTYROPHENONE; DOPAMINE 1 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; EMONAPRIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; PSYCHEDELIC AGENT; RACLOPRIDE; RECEPTOR RESERVE; SPIPERONE;

ARCHICORTEX; ARTICLE; AUTORADIOGRAPHY; BINDING AFFINITY; BINDING KINETICS; BINDING SITE; BRAIN CELL; CORPUS STRIATUM; DRUG SPECIFICITY; ENZYME ACTIVITY; HUMAN; INTERNALIZATION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SPECIES DIFFERENCE; STOICHIOMETRY;

ANIMALS; ANTIPSYCHOTIC AGENTS; BINDING SITES; BRAIN; BUTYROPHENONES; DOPAMINE AGENTS; HUMANS; LIGANDS; MAMMALS; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOISOTOPES; RECEPTORS, DOPAMINE;

EID: 79960019023     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20916     Document Type: Article

References (172)

1. Alttoa A, Seeman P, Koiv K, Eller M, Harro J. 2009. Rats with persistently high exploratory activity have both higher extracellular DA levels and higher proportion of D(2) (High) receptors in the striatum. Synapse 63: 443-446.
2. 3H]spiperone binding in brain indicate two states of the D2-DA receptor. Eur J Pharmacol 81: 493-498.
3. Beckstead RM, Wooten GF, Trugman JM. 1988. Distribution of D1 and D2 DA receptors in the basal ganglia of the cat determined by quantitative autoradiography. J Comp Neurol 268: 131-145.
4. 3H-spiperone binding in rat striatum: Implications for external imaging of DA receptors in Parkinson's disease. Ann Neurol 19: 378-383.
5. Beveridge TJ, Smith HR, Nader MA, Porrino LJ. 2009. Abstinence from chronic cocaine self-administration alters striatal DA systems in rhesus monkeys. Neuropsychopharmacology 34: 1162-1171.
6. Boyson SJ, McGonigle P, Molinoff PB. 1986. Quantitative autoradiographic localization of the D1 and D2 subtypes of DA receptors in rat brain. J Neurosci 6: 3177-3188.
7. Briand LA, Flagel SB, Seeman P, Robinson TE. 2008. Cocaine self-administration produces a persistent increase in DA D2 High receptors. Eur Neuropsychopharmacol 18: 551-556.
8. 11C]raclopride as measured by PET. Synapse 51: 27-31.
9. Carey MP, Diewald LM, Esposito FJ, Pellicano MP, Gironi Carnevale UA, Sergeant JA, Papa M, Sadile AG. 1998. Differential distribution, affinity and plasticity of DA D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD. Behav Brain Res 94: 173-185.
10. Chefer SI, Kimes AS, Matochik JA, Horti AG, Kurian V, Shumway D, Domino EF, London editors, Mukhin AG. 2008. Estimation of D2-like receptor occupancy by DA in the putamen of hemiparkinsonian Monkeys. Neuropsychopharmacology 33: 270-278.
11. Chen Y, Hillefors-Berglund M, Herrera-Marschitz M, Bjelke B, Gross J, Andersson K, von Euler G. 1997. Perinatal asphyxia induces long-term changes in DA D1. D2, and D3 receptor binding in the rat brain. Exp Neurol 146: 74-80.
12. Chou YH, Karlsson P, Halldin C, Olsson H, Farde L. 1999. A PET study of D(1)-like DA receptor ligand binding during altered endogenous DA levels in the primate brain. Psychopharmacology (Berl) 146: 220-227.
13. Christian BT, Narayanan T, Shi B, Morris editors, Mantil J, Mukherjee J. 2004. Measuring the in vivo binding parameters of [18F]-fallypride in monkeys using a PET multiple-injection protocol. J Cereb Blood Flow Metab 24: 309-322.
14. 3H]spiperone binding: Evidence for accumulation in corpus striatum by agonist-mediated receptor internalization. J Cereb Blood Flow Metab 8: 291-303.
15. Cumming P, Wong DF, Gillings N, Hilton J, Scheffel U, Gjedde A. 2002. Specific binding of [(11)C]raclopride and N-[(3)H]propyl-norapomorphine to DA receptors in living mouse striatum: Occupancy by endogenous DA and guanosine triphosphate-free G protein. J Cereb Blood Flow Metab 22: 596-604.
16. 11C]SKF 82957 in rat brain: Two DA D-1 receptor agonist ligands. Life Sci 58: 1661-1670.
17. Dewar KM, Paquet M, Reader TA. 1997. Alterations in the turnover rate of DA D1 but not D2 receptors in the adult rat neostriatum after a neonatal DA denervation. Neurochem Int 30: 613-621.
18. 11C]raclopride: Effect of methamphetamine. J Cereb Blood Flow Metab 23: 1489-1494.
19. 11C]raclopride. Synapse 44: 198-202.
20. 11C]raclopride. II. Effects of dopaminetransporter (DAT) inhibitors. J Cereb Blood Flow Metab 26: 28-37.
21. Duffy RA, Kaminska G, Chipkin RE, McQuade RD. 1992. Selective up-regulation of D-1 DA receptors following chronic administration of SCH 39166 in primates. Pharmacol Biochem Behav 41: 235-238.
22. Ekelund J, Slifstein M, Narendran R, Guillin O, Belani H, Guo NN, Hwang Y, Hwang DR, Abi-Dargham A, Laruelle M. 2007. In vivo DA D(1) receptor selectivity of NNC 112 and SCH 23390. Mol Imaging Biol 9: 117-125.
23. 11C]raclopride: Combined PET-microdialysis studies. J Cereb Blood Flow Metab 17: 932-942.
24. Farde L, Hall H, Ehrin E, Sedvall G. 1986. Quantitative analysis of D2 DA receptor binding in the living human brain by PET. Science 231: 258-261.
25. 11C]raclopride in man. Synapse 20: 200-208.
26. Feldman HA. 1983. Statistical limits in Scatchard analysis. J Biol Chem 258: 12865-12867.
27. 11C]MNPA. Synapse 63: 378-389.
28. Florijn WJ, Tarazi FI, Creese I. 1997. DA receptor subtypes: Differential regulation after eight months treatment with antipsychotic drugs. J Pharmacol Exp Ther 280: 561-569.
29. Fluegge G, Pfender D, Rudolph S, Jarry H, Fuchs E. 1999. 5HT1A-receptor binding in the brain of cyclic and ovariectomized female rats. J Neuroendocrinol 11: 243-249.
30. Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G. 1994. Expression and pharmacological characterization of the human D3 DA receptor. J Pharmacol Exp Ther 268: 417-426.
31. 11C]raclopride with ultra-high specific radioactivity. Nucl Med Biol 37: 831-835.
32. Gagnon C, Gomez-Mancilla B, Markstein R, Bedard PJ, Di Paolo T. 1995. Effect of adding the D-1 agonist CY 208-243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain DA receptors. Prog Neuropsychopharmacol Biol Psychiatry 19: 667-676.
33. Giardino L. 1996. Right-left asymmetry of D1- and D2-receptor Density is lost in the basal ganglia of old rats. Brain Res 720(1-2): 235-238.
34. 11C]raclopride binding to D2-DA receptors in the monkey brain. Synapse 25: 321-325.
35. 11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography. J Neurochem 97: 1089-1103.
36. 11C]raclopride positron emission tomography study in cats. Biol Psychiatry 55: 1188-1194.
37. Giorgi O, Biggio G. 1990. Selective unilateral inactivation of striatal D1 and D2 DA receptor subtypes by EEDQ: Turning behavior elicited by D2 DA receptor agonists. Brain Res 533: 53-59.
38. Gnanalingham KK, Hunter AJ, Jenner P, Marsden CD. 1994. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 DA receptors in the rat. Neuropharmacology 33: 647-655.
39. Goldsmith PC, Cronin MJ, Weiner RI. 1979. DA receptor sites in the anterior pituitary. J Histochem Cytochem 27: 1205-1207.
40. Goulet M, Grondin R, Morissette M, Maltais S, Falardeau P, Bedard PJ, Di Paolo T. 2000. Regulation by chronic treatment with cabergoline of DA D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys. Prog Neuropsychopharmacol Biol Psychiatry 24: 607-617.
41. 11C](+)-PHNO binding in human subjects by the DA D3 receptor antagonist ABT-925. Int J Neuropsychopharmacol 13: 273-287.
42. 11C]raclopride in healthy humans. Hum Brain Mapp 29: 400-410.
43. Graham WC, Clarke CE, Boyce S, Sambrook MA, Crossman AR, Woodruff GN. 1990a. Autoradiographic studies in animal models of hemi-parkinsonism reveal DA D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis). Brain Res 514: 103-110.
44. Graham WC, Crossman AR, Woodruff GN. 1990b. Autoradiographic studies in animal models of hemi-parkinsonism reveal DA D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Brain Res 514: 93-102.
45. Graham WC, Sambrook MA, Crossman AR. 1993. Differential effect of chronic dopaminergic treatment on DA D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism. Brain Res 602: 290-303.
46. Gredal O, Nielsen M. 1987. In situ molecular size of agonist DA D-2 binding sites in rat striatum. J Neurochem 48: 364-369.
47. Guo N, Guo W, Kralikova M, Jiang M, Schieren I, Narendran R, Slifstein M, Abi-Dargham A, Laruelle M, Javitch JA, Rayport S. 2010. Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers. Neuropsychopharmacology 235: 806-817.
48. Gurevich EV, Joyce JN. 1999. Distribution of DA D3 receptor expressing neurons in the human forebrain: Comparison with D2 receptor expressing neurons. Neuropsychopharmacology 20: 60-80.
49. Guttman M, Seeman P. 1985. L-dopa reverses the elevated density of D2 DA receptors in Parkinson's diseased striatum. J Neural Transm 64: 93-103.
50. 11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Res 82: 147-160.
51. Hall H, Wedel I. 1986. Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to DA-D2 receptors in the rat striatum. Acta Pharmacol et Toxicol 58: 368-373.
52. 3H]PD 128907. Psychopharmacology (Berl) 128: 240-247.
53. Hall H, Sedvall G, Magnusson O, Kopp J, Halldin C, Farde L. 1994. Distribution of D1- and D2-DA receptors, and DA and its metabolites in the human brain. Neuropsychopharmacology 11: 245-256.
54. 3H-raclopride to rat striatal DA-D2 receptors. Pharmacol Toxicol 63: 118-121.
55. 3H]raclopride to rat and human brain membranes. J Neurochem 55: 2048-2057.
56. 3H]-spiperone binding sites in the striatum and substantia nigra of the rat. Br J Pharmacol 79: 599-610.
57. 3H]N, n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. Biochem Pharmacol 32: 2973-2977.
58. Hamblin MW, Leff SE, Creese I. 1984. Interactions of agonists with D-2 DA receptors: Evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. Biochem Pharmacol 33: 877-887.
59. 3H]DA: Distribution, regulation and relationship to coupling. Neuroscience 46: 687-700.
60. 3H]SCH23390-labeled D1 DA receptors in rat striatum. Eur J Pharmacol 121: 31-38.
61. Hietala J, West C, Syvalahti E, Nagren K, Lehikoinen P, Sonninen P, Ruotsalainen U. 1994. Striatal D2 DA receptor binding characteristics in vivo in patients with alcohol dependence. Psychopharmacology (Berl) 116: 285-290.
62. Hillefors-Berglund M, Hedlund PB, von Euler G. 1995. Effects of CGS 21680 in vivo on DA D2 agonist binding in the rat brain. Brain Res 690: 34-40.
63. Holden JE, Jivan S, Ruth TJ, Doudet DJ. 2002. In vivo receptor assay with multiple ligand concentrations: An equilibrium approach. J Cereb Blood Flow Metab 22: 1132-1141.
64. 3H-N-methylspiperone. J Neural Transm 106(11-12): 1099-1104.
65. Itokawa M, Toru M, Ito K, Tsuga H, Kameyama K, Haga T, Arinami T Hamaguchi H. 1996. Sequestration of the short and long isoforms of DA D2 receptors expressed in Chinese Hamster ovary cells. Mol Pharmacol 49: 560-566.
66. Janson AM, Hedlund PB, Hillefors M, von Euler G. 1992. Chronic nicotine treatment decreases DA D2 agonist binding in the rat basal ganglia. Neuroreport 3: 1117-1120.
67. Jomphe C, Tiberi M, Trudeau LE. 2006. Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function. Neuropharmacology 50: 595-605.
68. 11C]N-methylspiperone. J Nucl Med 41: 65-70.
69. Karlsson P, Farde L, Halldin C, Sedvall G. 2002. PET study of D(1) DA receptor binding in neuroleptic-naive patients with schizophrenia. Am J Psychiatry 159: 761-767.
70. Kendall DA, Brown E, Nahorski SR. 1985. Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: Relationship between receptor occupancy and response and effects of denervation. Eur J Pharmacol 114: 41-52.
71. Kleuss C, Krause E. 2003. Galpha(s) is palmitoylated at the N-terminal glycine. EMBO J 22: 826-832.
72. Ko F, Seeman P, Sun WS, Kapur S. 2002. DA D2 receptors internalize in their low affinity state. Neuroreport 13: 1017-1020.
73. Koeltzow TE, Xu M, Cooper DC, Hu XT, Tonegawa S, Wolf ME, White FJ. 1998. Alterations in DA release but not DA autoreceptor function in DA D3 receptor mutant mice. J Neurosci 18: 2231-2238.
74. 11C]SB207145 in the Gottingen minipig. J Cereb Blood Flow Metab 29: 186-196.
75. Kortekaas R, Maguire RP, Cremers TI, Dijkstra D, van Waarde A, Leenders KL. 2004. In vivo binding behavior of DA receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta. J Cereb Blood Flow Metab 24: 531-535.
76. Lai H, Bowden DM, Horita A. 1987. Age-related decreases in DA receptors in the caudate nucleus and putamen of the rhesus monkey (Macaca mulatta). Neurobiol Aging 8: 45-49.
77. Laruelle M, Iyer RN, al-Tikriti MS, Zea-Ponce Y, Malison R, Zoghbi SS, Baldwin RM, Kung HF, Charney DS, Hoffer PB, Innis RB, Bradberry CW. 1997. Microdialysis and SPECT measurements of amphetamine-induced DA release in nonhuman primates. Synapse 25: 1-14.
78. 3H]spiperone. Eur J Pharmacol 81: 273-285.
79. 3H]DA can label a high affinity agonist-binding state of the D1 DA receptor. Mol Pharmacol 27: 184-192.
80. 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states. Mol Pharmacol 27: 171-183.
81. 3H]spiperone binds selectively to rat striatal D2 DA receptors in vivo: A kinetic and pharmacological analysis. Brain Res 407: 253-262.
82. 3H]quinpirole binding to D2-like DA receptors in rat brain. J Pharmacol Exp Ther 262: 929-935.
83. 3H]quinpirole binding to putative D2 and D3 DA receptors in rat brain and pituitary gland: A quantitative autoradiographic study. J Pharmacol Exp Ther 264: 991-1001.
84. Li XM, Hedlund PB, Fuxe K. 1995. Cholecystokinin octapeptide in vitro and ex vivo strongly modulates striatal DA D2 receptors in rat forebrain sections. Eur J Neurosci 7: 962-971.
85. 11C]flumazenil and positron emission tomography. Epilepsia 50: 88-98.
86. Loopuijt LD, Hovda DA, Ebrahim A, Villablanca JR, Chugani HT. 1998. Differences in D2 DA receptor binding in the neostriatum between cats hemidecorticated neonatally or in adulthood. Brain Res Dev Brain Res 107: 113-122.
87. 3H-3-N-methylspiperone labels D2 DA receptors in basal ganglia and S2 serotonin receptors in cerebral cortex. J Neurosci 6: 2941-2949.
88. Malmberg A, Jerning E, Mohell N. 1996. Critical reevaluation of spiperone and benzamide binding to DA D2 receptors: evidence for identical binding sites. Eur J Pharmacol 303(1-2): 123-128.
89. 11C]SB207145-PET. Neuroimage 50: 855-861.
90. 3H]raclopride is increased in schizophrenia. Biol Psychiatry 42: 648-654.
91. McCormick PN, Kapur S, Seeman P, Wilson AA. 2008. DA D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo. Nucl Med Biol 35: 11-17.
92. 11C]-(+)-PHNO binding is unchanged in animal models displaying increased high-affinity states of the D2 receptor in vitro. Synapse 63: 998-1009.
93. McCormick PN, Ginovart N, Wilson AA. 2010. Isoflurane anaesthesia differentially affects the amphetamine sensitivity of agonist and antagonist D2/D3 positron emission tomography radiotracers: Implications for in vivo imaging of DA release. Mol Imaging Biol 2010 Aug 3. [Epub ahead of print].
94. McLeod MC, Sundram S, Dean B. 2008. Treatment with haloperidol and diazepam alters GABAA receptor density in the rat brain. Prog Neuropsychopharmacol Biol Psychiat 32: 560-567.
95. Meller E, Helmer-Matyjek E, Bohmaker K, Adler CH, Friedhoff AJ, Goldstein M. 1986. Receptor reserve at striatal DA autoreceptors: Implications for selectivity of DA agonists. Eur J Pharmacol 123: 311-314.
96. Mezzomo K, Cumming P, Minuzzi L. 2007. Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography. Eur J Pharmacol 564: 75-79.
97. Millan MJ. 2010. From the cell to the clinic: A comparative review of the partial D(2)/D(3) receptor agonist and alpha(2)-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease. 2010. Pharmacol Ther 128: 229-273.
98. Mintun MA, Raichle ME, Kilbourn MR, Wooten GF, Welch MJ. 1984. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 15: 217-227.
99. Minuzzi L, Cumming P. 2010. Agonist binding fraction of DA D2/3 receptors in rat brain: A quantitative autoradiographic study. Neurochem Int 56(6-7): 747-747.
100. Minuzzi L, Olsen AK, Bender D, Arnfred S, Grant R, Danielsen EH, Cumming P. 2006. Quantitative autoradiography of ligands for DA receptors and transporters in brain of Gottingen minipig: Comparison with results in vivo. Synapse 59: 211-219.
101. Montague DM, Lawler CP, Mailman RB, Gilmore JH. 1999. Developmental regulation of the DA D1 receptor in human caudate and putamen. Neuropsychopharmacology 21: 641-649.
102. Montague DM, Striplin CD, Overcash JS, Drago J, Lawler CP, Mailman RB. 2001. Quantification of D1B(D5) receptors in DA D1A receptor-deficient mice. Synapse 39: 319-322.
103. Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP. 1998a. Effect of cocaine self-administration on DA D2 receptors in rhesus monkeys. Synapse 30: 88-96.
104. Moore RJ, Vinsant SL, Nader MA, Porrino LJ, Friedman DP. 1998b. Effect of cocaine self-administration on striatal DA D1 receptors in rhesus monkeys. Synapse 28: 1-9.
105. Morris editors, Yoder KK. 2007. Positron emission tomography displacement sensitivity: Predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics. J Cereb Blood Flow Metab 27: 606-617.
106. Munemura M, Agui T, Sibley DR. 1989. Chronic estrogen treatment promotes a functional uncoupling of the D2 DA receptor in rat anterior pituitary gland. Endocrinology 124: 346-355.
107. 11C]raclopride in baboons. J Pharmacol Exp Ther 315: 80-90.
108. 11C]-raclopride. Synapse 52: 188-208.
109. 3H]spiroperidol binding to rat forebrain sections: Plasticity of neostriatal DA receptors after nigrostriatal injury. Brain Res 302: 9-18.
110. Nikolaus S, Larisch R, Beu M, Hamacher K, Forutan F, Vosberg H, Muller HW. 2003. In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals. J Nucl Med 44: 618-624.
111. 3H]-YM-09151-2. Naunyn Schmiedebergs Arch Pharmacol 329: 333-343.
112. 3H](+)PHNO. Synapse 17: 167-172.
113. 11C]N-methylspiperone. Psychiatry Res 61: 67-83.
114. Ostergaard SD, Alstrup AK, Gramsbergen JB, Minuzzi L, Pedersen K, Jensen SB, Doudet D, Cumming P. 2010. MDMA-evoked changes in the binding of DA D(2) receptor ligands in striatum of rats with unilateral serotonin depletion. Synapse 64: 70-82.
115. 3H]raclopride binding to the DA D2 receptor. Acta Pharm Res 23: 350-356.
116. Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D. 2010. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [(3)H]-MNPA, [(3)H]-(+)-PHNO, and [(3)H]-raclopride. Synapse 64: 624-633.
117. Perlmutter JS, Raichle ME. 1986. In vitro or in vivo receptor binding: where does the truth lie? Ann Neurol 19: 384-385.
118. 3H]NGD 94-1. J Pharmacol Exp Ther 282: 1020-1027.
119. Rabiner EA, Slifstein M, Nobrega J, Plisson C, Huiban M, Raymond R, Diwan M, Wilson AA, McCormick P, Gentile G, Gunn RN, Laruelle MA. 2009. In vivo quantification of regional DA-D3 receptor binding potential of (+)-PHNO: Studies in non-human primates and transgenic mice. Synapse 63: 782-793.
120. Rao PA, Molinoff PB, Joyce JN. 1991. Ontogeny of DA D1 and D2 receptor subtypes in rat basal ganglia: A quantitative autoradiographic study. Brain Res Dev Brain Res 60: 161-177.
121. 3H]raclopride. Biochem Pharmacol 40: 1739-1746.
122. Richfield EK, Young AB, Penney JB. 1986. Properties of D2 DA receptor autoradiography: High percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections. Brain Res 383(1-2): 121-128.
123. Richfield EK, Young AB, Penney JB. 1987. Comparative distribution of DA D-1 and D-2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys. J Comp Neurol 262: 446-463.
124. Ridd MJ, Kitchen I, Fosbraey P. 1998. The effect of acute kainic acid treatment on DA D2 receptors in rat brain. Neurosci Res 30: 201-211.
125. 11C]raclopride. J Cereb Blood Flow Metab 13: 310-314.
126. Rinne JO, Laihinen A, Lonnberg P, Marjamaki P, Rinne UK. 1991. A post-mortem study on striatal DA receptors in Parkinson's disease. Brain Res 556: 117-122.
127. 11C]raclopride. J Neurol Sci 132: 156-161.
128. Rinne JO, Lonnberg P, Marjamaki P. 1990. Age-dependent decline in human brain DA D1 and D2 receptors. Brain Res 508: 349-352.
129. 11C]NMSP binding in living pig brain. Synapse 53: 222-233.
130. Roseboom PH, Gnegy ME. 1989. Acute in vivo amphetamine produces homologous desensitization of DA receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site. Mol Pharmacol 34: 148-156.
131. Rosengarten H, Schweitzer JW, Friedhoff AJ. 1989. A full repetitive jaw movement response after 70% depletion of caudate D1 receptors. Pharmacol Biochem Behav 34: 895-897.
132. 3H-raclopride in the mouse brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 340: 6-12.
133. 3H-(-)-N-n-propylnorapomorphine in mouse brain. Naunyn Schmiedebergs Arch Pharmacol 340: 13-20.
134. 11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique. Synapse 44: 42-50.
135. Schwartz RA, Greenwald ER, Fletcher PJ, Houle S, DaSilva JN. 2003. Up-regulated DA D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxyDA, treatments. Eur J Pharmacol 459(2-3): 195-201.
136. Seeman P. 1987. The absolute density of neurotransmitter receptors in the brain. Example for DA receptors. J Pharmacol Methods 17: 347-360.
137. Seeman P, Bzowej NH, Guan HC, Bergeron C, Becker LE, Reynolds GP, Bird editors, Riederer P, Jellinger K, Watanabe S, et al. 1987. Human brain DA receptors in children and aging adults. Synapse 1: 399-404.
138. Seeman P, Guan HC. 2008. Phencyclidine and glutamate agonist LY379268 stimulate DA D2High receptors: D2 basis for schizophrenia. Synapse 62: 819-828.
139. Seeman P, Guan HC, Hirbec H. 2009. DA D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. Synapse 63: 698-704.
140. Seeman P, Ko F, Willeit M, McCormick P, Ginovart N. 2005. Antiparkinson concentrations of pramipexole and PHNO occupy DA D2(high) and D3(high) receptors. Synapse 58: 122-128.
141. Seeman P, McCormick PN, Kapur S. 2007. Increased DA D2(High) receptors in amphetamine-sensitized rats, measured by the agonist [(3)H](+)PHNO. Synapse 61: 263-267.
142. 3H]spiperone in isotonic medium: Implications for human positron emission tomography. Synapse 49: 209-215.
143. Seeman P, Tallerico T, Ko F, Tenn C, Kapur S. 2002. Amphetamine-sensitized animals show a marked increase in DA D2 high receptors occupied by endogenous DA, even in the absence of acute challenges. Synapse 46: 235-239.
144. 11C]raclopride. Synapse 59: 260-269.
145. Sibley DR, De Lean A, Creese I. 1982. Anterior pituitary DA receptors. Demonstration of interconvertible high and low affinity states of the D-2 DA receptor. J Biol Chem 257: 6351-6361.
146. Sibley DR, Mahan LC, Creese I. 1983. DA receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. Mol Pharmacol 23: 295-302.
147. Simola N, Morelli M, Seeman P. 2008. Increase of DA D2(High) receptors in the striatum of rats sensitized to caffeine motor effects. Synapse 62: 394-397.
148. Skinbjerg M, Namkung Y, Halldin C, Innis RB, Sibley DR. 2009. Pharmacological characterization of 2-methoxy-N-propylnorapomorphine's interactions with D2 and D3 DA receptors. Synapse 63: 462-475.
149. Skinbjerg M, Liow JS, Seneca N, Hong J, Lu S, Thorsell A, Heilig M, Pike VW, Halldin C, Sibley DR, Innis RB. 2010. D2 DA receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model. Neuroimage 50: 1402-1407.
150. 11C]NNC 112 selectivity for DA D1 and serotonin 5-HT(2A) receptors: A PET study in healthy human subjects. J Cereb Blood Flow Metab 27: 1733-1741.
151. 11C]raclopride. J Cereb Blood Flow Metab 31: 293-304.
152. Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. 2006. Molecular biology, pharmacology and functional role of the plasma membrane DA transporter. CNS Neurol Disord Targets 5: 45-56.
153. Spinelli S, Chefer S, Carson RE, Jagoda E, Lang L, Heilig M, Barr CS, Suomi SJ, Higley JD, Stein EA. 2009. Effects of early-life stress on serotonin1A receptors in juvenile rhesus monkeys measured by positron emission tomography. Biol Psychiat 67: 1146-1153.
154. 3H]spiperone. Mol Pharmacol 63: 456-462.
155. 3H]raclopride in postmortem human brains. Brain Res 765: 7-12.
156. 3H]raclopride for DA d-2 receptor binding to rat striatum. Eur J Pharmacol 173(2-3): 177-182.
157. Tsukada H, Kreuter J, Maggos CE, Unterwald EM, Kakiuchi T, Nishiyama S, Futatsubashi M, Kreek MJ. 1996. Effects of binge pattern cocaine administration on DA D1 and D2 receptors in the rat brain: An in vivo study using positron emission tomography. J Neurosci 16: 7670-7677.
158. Tupala E, Tiihonen J. 2005. Striatal DA D1 receptors in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Brain Res 1031: 20-29.
159. 11C]-(+)-PHNO: Dissection of D3 signal and anatomy. Neuroimage 54: 264-277.
160. 3H-(-)-sulpiride to DA D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands. Naunyn Schmiedebergs Arch Pharmacol 335: 115-122.
161. Van der Werf JF, Sebens JB, Korf J. 1984. In vivo binding of N-n-propylnorapomorphine in the rat striatum: Quantification after lesions produced by kainate, 6-hydroxyDA and decortication. Eur J Pharmacol 102: 251-259.
162. Van der Werf JF, Sebens JB, Korf J. 1986. Tracer and maximal specific binding of tritiated spiperone or N-n-propylnorapomorphine to quantify DA receptors in rat brain regions in vivo. Life Sci 39: 155-160.
163. Videbaek C, Toska K, Scheideler MA, Paulson OB, Moos Knudsen G. 2000. SPECT tracer [(123)I]IBZM has similar affinity to DA D2 and D3 receptors. Synapse 38: 338-342.
164. 3H]spiperone label equivalent numbers of D2 and D3 DA receptors in a range of tissues and under different conditions. J Neurochem 64: 940-943.
165. Wanderoy MH, Westlind-Danielsson A, Ahlenius S. 1997. DA D2 receptor upregulation in rat neostriatum following in vivo infusion of forskolin. Neuroreport 8: 2971-2976.
166. Wong DF, Pearlson GD, Tune LE, Young LT, Meltzer CC, Dannals RF, Ravert HT, Reith J, Kuhar MJ, Gjedde A. 1997. Quantification of neuroreceptors in the living human brain. IV. Effect of aging and elevations of D2-like receptors in schizophrenia and bipolar illness. J Cereb Blood Flow Metab 17: 331-342.
167. Wong DF, Wagner HNJr, Tune LE, Dannals RF, Pearlson GD, Links JM, Tamminga CA, Broussolle EP, Ravert HT, Wilson AA, Toung JK, Malat J, Williams JA, O'Tuama LA, Snyder SH, Kuhar MJ, Gjedde A. 1986. Positron emission tomography reveals elevated D2 DA receptors in drug-naive schizophrenics. Science 234: 1558-1563.
168. 3H]DA. Eur J Pharmacol 155: 323-327.
169. 3H]raclopride binding in the rat brain. Synapse 9: 188-194.
170. 3H]-spiperone in striatum. J Pharmacol Exp Therap 227: 592-599.
171. Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF, George SR. 1998. DA D2 receptor dimers in human and rat brain. FEBS Lett 441: 383-386.
172. Zeng BY, Heales SJ, Canevari L, Rose S, Jenner P. 2004. Alterations in expression of DA receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice. Exp Neurol 190: 515-524.